Article
Machine learning engineered PoLixNano nanoparticles overcome delivery barriers for nebulized mRNA therapeutics
2024-11-04
Abstract excerpt
There continues to be a dearth of competent inhalable mRNA delivery although it holds great potential for addressing a wide variety of refractory diseases. The huge advances seen with parenteral-administered lipid nanoparticle (LNP) have not been translated into nebulized mRNA delivery due to the aggressive nebulization process and insurmountable barriers inherent to respiratory mucosa. Here, we show amphiphilic b...
Topics
Open a Topic to create a Post that cites this publication.
- Animal Virus Infections Studies
- Immunotherapy and Immune Responses
- Inhalation and Respiratory Drug Delivery
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Occupational exposure and asthma
- RNA Interference and Gene Delivery
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- 554efd14-f79e-5b77-a51d-5f393c238b65
- DOI
- 10.1101/2024.11.03.621713
